
Find Reports
Select Report Type
Reimbursement Review
Displaying 1176 - 1200 of 1404
Please scroll or swipe to the right to view the full content.
Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
---|---|---|---|---|---|---|---|---|---|
asciminibOpens in new tab | Scemblix | asciminib | Philadelphia chromosome-positive chronic myeloid leukemia | Pending | PC0405-000 | ||||
pembrolizumabOpens in new tab | Keytruda | pembrolizumab | Head and neck squamous cell carcinoma | Pending | PC0410-000 | ||||
guselkumabOpens in new tab | Tremfya | guselkumab | Crohn’s disease | Active | SR0882-000 | ||||
risperidoneOpens in new tab | Okedi | risperidone | Schizophrenia, adults | Pending | SR0879-000 | ||||
pembrolizumabOpens in new tab | Keytruda | pembrolizumab | Cervical cancer | Pending | PC0411-000 | ||||
acalabrutinibOpens in new tab | Calquence | acalabrutinib | Mantle cell lymphoma (MCL) | Pending | PC0413-000 | ||||
nivolumab and IpilimumabOpens in new tab | Opdivo and Yervoy | nivolumab and Ipilimumab | Unresectable or metastatic MSI-H or dMMR colorectal cancer | Pending | PC0396-000 | ||||
MelanomaOpens in new tab | Melanoma | Open for Input | PH0072-000 | ||||||
talazoparibOpens in new tab | Talzenna | talazoparib | Metastatic castration-resistant prostate cancer | Pending | PC0417-000 | ||||
asciminibOpens in new tab | Scemblix | asciminib | Philadelphia chromosome-positive chronic myeloid leukemia | Pending | PC0418-000 | ||||
risankizumabOpens in new tab | Skyrizi | risankizumab | Ulcerative colitis | Pending | SR0890-000 | ||||
Large B-Cell LymphomaOpens in new tab | Large B-Cell Lymphoma | Completed | PH0027-000 | ||||||
RET fusion-positive non-small ...Opens in new tab | RET fusion-positive non-small cell lung cancer | Complete | PH0026-000 | ||||||
brentuximab vedotinOpens in new tab | Adcetris | brentuximab vedotin | Hodgkin lymphoma | Withdrawn | PC0311-000 | ||||
Non-Small Cell Lung Cancer (NS...Opens in new tab | Non-Small Cell Lung Cancer (NSCLC) with Activating Epidermal Growth Factor Receptor (EGFR) Mutations | Complete | PH0028-000 | ||||||
CADTH Pharmaceutical Reviews U...Opens in new tab | |||||||||
Prostate cancerOpens in new tab | Prostate Cancer | Complete | PH0023-000 | ||||||
anakinraOpens in new tab | Kineret | anakinra | Still's disease | Withdrawn | SR0662-000 | ||||
Adult B-Cell Precursor Acute L...Opens in new tab | B-Cell Precursor Acute Lymphoblastic Leukemia | Complete | PH0002-000 | ||||||
CADTH Pharmaceutical Reviews U...Opens in new tab | |||||||||
HER2-Positive Metastatic Breas...Opens in new tab | HER2-Positive Metastatic Breast Cancer | Complete | PH0006-000 | ||||||
Adult Classical Hodgkin Lympho...Opens in new tab | Complete | PH0007-000 | |||||||
CADTH Pharmaceutical Reviews U...Opens in new tab | |||||||||
CADTH Pharmaceutical Reviews U...Opens in new tab | |||||||||
HR+ HER2- Breast Cancer and Tr...Opens in new tab | HR+ HER2- Breast Cancer and Triple Negative Breast Cancer, with inclusion of HER2 Low Breast Cancer | Complete | PH0033-000 |
Health Technology Review
Displaying 576 - 591 of 591
Horizon Scan
Displaying 101 - 111 of 111
Projects in Progress
Displaying 26 - 37 of 37
View All Reports
Displaying 1176 - 1200 of 2106
Please scroll or swipe to the right to view the full content.